Search Results - "Vogl, D"

Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis by JANNI, Wolfgang, VOGL, Florian D, SOLOMAYER, Erich, PANTEL, Klaus, NESLAND, Jahn, FRIESE, Klaus, NAUME, Bjorn, WIEDSWANG, Gro, SYNNESTVEDT, Marit, FEHM, Tanja, JÜCKSTOCK, Julia, BORGEN, Elin, RACK, Brigitte, BRAUN, Stephan, SOMMER, Harald

“…The prognostic significance of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients at the time of primary diagnosis has been confirmed…”
Get full text

Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma by Olin, R L, Vogl, D T, Porter, D L, Luger, S M, Schuster, S J, Tsai, D E, Siegel, D L, Cook, R J, Mangan, P A, Cunningham, K, Stadtmauer, E A

“…Therapeutic options for patients with multiple myeloma whose disease has relapsed after a prior auto-SCT include novel biologic therapies, traditional…”
Get full text

Classifying ultra-high risk smoldering myeloma by Waxman, A J, Mick, R, Garfall, A L, Cohen, A, Vogl, D T, Stadtmauer, E A, Weiss, B M

Get full text

CB‐103: A novel CSL‐NICD inhibitor for the treatment of NOTCH‐driven T‐cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T‐ALL by Medinger, Michael, Junker, Till, Heim, Dominik, Tzankov, Alexandar, Jermann, Philip M., Bobadilla, Maria, Vigolo, Michele, Lehal, Rajwinder, Vogl, Florian D., Bauer, Michael, Passweg, Jakob

“…Relapsed T cell acute lymphoblastic leukaemia (T‐ALL) has a very poor prognosis. A 24‐year‐old patient with relapsed high‐risk T‐ALL (PTEN gene deletion;…”
Get full text

Trimming the fat: obesity and hematopoietic cell transplantation by Weiss, B M, Vogl, D T, Berger, N A, Stadtmauer, E A, Lazarus, H M

“…Obesity, increasing worldwide, is common in patients undergoing hematopoietic cell transplantation (HCT). This complex physiological state may alter the…”
Get full text

Inter- and intra-observer agreement of BI-RADS-based subjective visual estimation of amount of fibroglandular breast tissue with magnetic resonance imaging: comparison to automated quantitative assessment by Wengert, G. J., Helbich, T. H., Woitek, R., Kapetas, P., Clauser, P., Baltzer, P. A., Vogl, W-D., Weber, M., Meyer-Baese, A., Pinker, Katja

“…Purpose To evaluate the inter-/intra-observer agreement of BI-RADS-based subjective visual estimation of the amount of fibroglandular tissue (FGT) with…”
Get full text

Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim by Xu, H., Gong, Q., Vogl, F. D., Reiner, M., Page, J. H.

“…Purpose The purpose of this study was to evaluate risk factors for bone pain in patients receiving myelosuppressive chemotherapy and pegfilgrastim. Methods…”
Get full text

Cellular immunotherapy for plasma cell myeloma by Garfall, A L, Vogl, D T, Weiss, B M, Stadtmauer, E A

“…Allogeneic hematopoietic cell transplantation for plasma cell myeloma can lead to graft-vs-myeloma immunity and long-term survivorship, but limited efficacy…”
Get full text

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two‐Arm Prospective Trial by Tsai, D. E., Douglas, L., Andreadis, C., Vogl, D. T., Arnoldi, S., Kotloff, R., Svoboda, J., Bloom, R. D., Olthoff, K. M., Brozena, S. C., Schuster, S. J., Stadtmauer, E. A., Robertson, E. S., Wasik, M. A., Ahya, V. N.

“…While EBV PCR is used in the management of PTLD, the optimal primer set, relative importance of intracellular versus free plasma EBV, and the baseline profile…”
Get full text

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT by Tizon, R, Frey, N, Heitjan, D F, Tan, K S, Goldstein, S C, Hexner, E O, Loren, A, Luger, S M, Reshef, R, Tsai, D, Vogl, D, Davis, J, Vozniak, M, Fuchs, B, Stadtmauer, E A, Porter, D L

“…Idiopathic Pneumonia Syndrome (IPS) is a common complication after allo-SCT and results in high mortality rates. Conventional treatment for IPS typically…”
Get full text

Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen by Nazha, A, Cook, R, Vogl, D T, Mangan, P A, Gardler, M, Hummel, K, Cunningham, K, Luger, S M, Porter, D L, Schuster, S, O'Doherty, U, Siegel, D, Stadtmauer, E A

“…Lenalidomide is an active treatment for multiple myeloma (MM) and is increasingly used as part of the initial treatment of this disease. Recent reports have…”
Get full text

Glutathione S-transferases M1, T1, and P1 and Breast Cancer: A Pooled Analysis by Vogl, Florian D, Taioli, Emanuela, Maugard, Christine, Zheng, Wei, Pinto, Luis F Ribeiro, Ambrosone, Christine, Parl, Fritz F, Nedelcheva-Kristensen, Vessela, Rebbeck, Timothy R, Brennan, Paul, Boffetta, Paolo

“…The glutathione S -transferase ( GST ) genes are involved in the metabolism of various carcinogens. Deletion polymorphisms in the genes GSTM1 and GSTT1 and a…”
Get full text

Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa by Rogler, Gerhard, Brand ‡, Korbinian, Vogl, Daniela, Page ‡, Sharon, Hofmeister, Robert, Andus, Tilo, Knuechel §, Ruth, Baeuerle ∥, Patrick A., Schölmerich, Jürgen, Gross, Volker

“…Background & Aims: Transcription factors of the nuclear factor κB (NF-κB) family play an important role in the regulation of genes involved in inflammation. In…”
Get full text

Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based Study by Pal, Tuya, Vogl, Florian D., Chappuis, Pierre O., Tsang, Richard, Brierley, James, Renard, Helene, Sanders, Kevin, Kantemiroff, Tania, Bagha, Sabira, Goldgar, David E., Narod, Steven A., Foulkes, William D.

“…The genetic basis for nonmedullary forms of thyroid cancer (NMTC) is less well established than that of medullary thyroid cancer. However, epidemiological and…”
Get full text

Association between mobilization regimen and PFS after auto-SCT for multiple myeloma by Garfall, A L, Dougherty, A L, Vogl, D T, Weiss, B M, Cohen, A D, Mick, R, O'Doherty, U, Stadtmauer, E A

Get full text

Chemotherapy treatment patterns and neutropenia management in gastric cancer by Kalinka-Warzocha, Ewa, Plazas, Javier Gallego, Mineur, Laurent, Salek, Tomas, Hendlisz, Alain, DeCosta, Lucy, Vogl, Florian D., Passalacqua, Rodolfo

“…Background Potentially myelosuppressive doublet and triplet chemotherapy combination regimens are considered the most active treatments in gastric cancer. This…”
Get full text

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed by Vogl, D T, Stadtmauer, E A

Get full text

Isolation and phenotypic characterization of colonic macrophages by ROGLER, G, HAUSMANN, M, VOGL, D, ASCHENBRENNER, E, ANDUS, T, FALK, W, ANDREESEN, R, SCHÖLMERICH, J, GROSS, V

“…Macrophages play an important role in the intestinal mucosal immune system. However, they are a poorly defined cell population. We therefore determined their…”
Get full text

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB) by Mayer, Ingrid A, Prat, Aleix, Egle, Daniel, Blau, Sibel, Fidalgo, J Alejandro Pérez, Gnant, Michael, Fasching, Peter A, Colleoni, Marco, Wolff, Antonio C, Winer, Eric P, Singer, Christian F, Hurvitz, Sara, Estévez, Laura García, van Dam, Peter A, Kümmel, Sherko, Mundhenke, Christoph, Holmes, Frankie, Babbar, Naveen, Charbonnier, Laure, Diaz-Padilla, Ivan, Vogl, Florian D, Sellami, Dalila, Arteaga, Carlos L

“…Addition of alpelisib to fulvestrant significantly extended progression-free survival in -mutant, hormone receptor-positive (HR ) advanced/metastatic breast…”
Get full text

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation by Uy, G L, Costa, L J, Hari, P N, Zhang, M-J, Huang, J-X, Anderson, K C, Bredeson, C N, Callander, N S, Cornell, R F, Perez, M A D, Dispenzieri, A, Freytes, C O, Gale, R P, Garfall, A, Gertz, M A, Gibson, J, Hamadani, M, Lazarus, H M, Kalaycio, M E, Kamble, R T, Kharfan-Dabaja, M A, Krishnan, A Y, Kumar, S K, Kyle, R A, Landau, H J, Lee, C H, Maiolino, A, Marks, D I, Mark, T M, Munker, R, Nishihori, T, Olsson, R F, Ramanathan, M, Rodriguez, T E, Saad, A A, Savani, B N, Schiller, G J, Schouten, H C, Schriber, J R, Scott, E, Seo, S, Sharma, M, Ganguly, S, Stadtmauer, E A, Tay, J, To, L B, Vesole, D H, Vogl, D T, Wagner, J L, Wirk, B, Wood, W A, D'Souza, A

“…In patients with multiple myeloma (MM) undergoing autologous hematopoietic cell transplantation (auto-HCT), peripheral blood progenitor cells may be collected…”
Get full text